1. Anti-CAR-engineered T cells for epitope-based elimination of autologous CAR T cells

   • Stefanie Koristka
   • Pauline Ziller-Walter
   • Michael P. Bachmann

   Original Article Open access 14 August 2019 Pages: 1401 - 1415

   

2. Successful combination therapy of systemic checkpoint inhibitors and intralesional interleukin-2 in patients with metastatic melanoma with primary therapeutic resistance to checkpoint inhibitors alone

   • David Rafei-Shamsabadi
   • Saskia Lehr
   • Frank Meiss

   Original Article 17 August 2019 Pages: 1417 - 1428

   

3. A VEGFR2–MICA bispecific antibody activates tumor-infiltrating lymphocytes and exhibits potent anti-tumor efficacy in mice

   • Yao Xu
   • Xinrong Zhang
   • Juan Zhang

   Original Article 19 August 2019 Pages: 1429 - 1441

   

4. Morphomolecular analysis of the immune tumor microenvironment in human head and neck cancer

   • Mohamed Badr
   • Korinna Jöhrens
   • Jan Budczies

   Original Article 23 August 2019 Pages: 1443 - 1454

   

5. Melanoma-conditioned medium promotes cytotoxic immune responses by murine bone marrow-derived monocytes despite their expression of ‘M2’ markers

   • Liam Friel Tremble
   • Anne C. Moore
   • Patrick F. Forde

   Original Article 23 August 2019 Pages: 1455 - 1465

   

6. Safety and efficacy of PD-1 blockade-activated multiple antigen-specific cellular therapy alone or in combination with apatinib in patients with advanced solid tumors: a pooled analysis of two prospective trials

   • Lijun Liang
   • Yixuan Wen
   • Xiaodong Jiang

   Original Article 27 August 2019 Pages: 1467 - 1477

   

7. An optimized retinoic acid-inducible gene I agonist M8 induces immunogenic cell death markers in human cancer cells and dendritic cell activation

   • Luciano Castiello
   • Alessandra Zevini
   • John Hiscott

   Original Article 28 August 2019 Pages: 1479 - 1492

   

8. TNFSF4 (OX40L) expression and survival in locally advanced and metastatic melanoma

   • Jason Roszik
   • Ettai Markovits
   • Raya Leibowitz-Amit

   Original Article 09 September 2019 Pages: 1493 - 1500

   

9. Tumor-induced peripheral immunosuppression promotes brain metastasis in patients with non-small cell lung cancer

   • Yuping D. Li
   • Jonathan B. Lamano
   • Orin Bloch

   Original Article 05 September 2019 Pages: 1501 - 1513

   

10. Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signature

    • Emily Hinchcliff
    • Cherie Paquette
    • Amir Jazaeri

    Original Article 12 September 2019 Pages: 1515 - 1526

    

11. Anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer

    • Danyang Sun
    • Junxun Ma
    • Yi Hu

    Original Article Open access 18 September 2019 Pages: 1527 - 1535

    

12. Independent expression of circulating and tissue levels of PD-L1: correlation of clusters with tumor metabolism and outcome in patients with non-small cell lung cancer

    • Fabio Grizzi
    • Angelo Castello
    • Egesta Lopci

    Original Article 03 September 2019 Pages: 1537 - 1545

    

13. A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients

    • Benjamin Weide
    • Thomas Eigentler
    • Claus Garbe

    Clinical Trial Report 03 September 2019 Pages: 1547 - 1559